| |
 |
|
Class Information
Number: 530/388.1
Name: Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof > Proteins, i.e., more than 100 amino acid residues > Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc. > Globulins > Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed > Monoclonal
Description: Subject matter involving an antibody or fragment thereof produced by a clone of cells or cell line that is derived from a single antibody-producing cell, wherein said antibody is identical to all other antibodies produced by that clone of cells or cell line.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 530/388.9 |
Binds drug, hapten, hapten--carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.) |
282 |
| 530/388.2 |
Binds microorganism or normal or mutant component or product thereof (e.g., animal cell, cell-surface antigen, secretory product, etc.) |
893 |
| 530/388.15 |
Human |
585 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7626002 |
Cytokine zalpha11 ligand antibodies |
Dec. 1, 2009 |
| 7625859 |
HER-2 binding antagonists |
Dec. 1, 2009 |
| 7625710 |
Methods for determining 2F1-binding compounds |
Dec. 1, 2009 |
| 7622560 |
Monoclonal antibody specific for CD43 epitope |
Nov. 24, 2009 |
| 7622559 |
Human monoclonal antibodies against interleukin 8 (IL-8) |
Nov. 24, 2009 |
| 7622558 |
Antibodies which are directed against the Marburg I polymorphism of factor VII-activating protease (FSAP), and their preparation and use |
Nov. 24, 2009 |
| 7622113 |
Monoclonal antibodies that bind or neutralize dengue virus |
Nov. 24, 2009 |
| 7619071 |
Antibodies that bind interleukin-17 receptor homologue |
Nov. 17, 2009 |
| 7619068 |
Ovr110 antibody compositions and methods of use |
Nov. 17, 2009 |
| 7618783 |
Anthrax specific antibodies |
Nov. 17, 2009 |
| 7618629 |
Manipulation of cytokine levels using CD83 gene products |
Nov. 17, 2009 |
| 7615616 |
Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
Nov. 10, 2009 |
| 7615529 |
Methods and compositions for modulating hyperstabilized c-met |
Nov. 10, 2009 |
| 7615372 |
Antibodies with immune effector activity and that internalize in endosialin-positive cells |
Nov. 10, 2009 |
| 7615215 |
Anti-human VEGF receptor Flt-1 monoclonal antibody |
Nov. 10, 2009 |
| 7615214 |
Anti-human VEGF receptor Flt-1 monoclonal antibody |
Nov. 10, 2009 |
| 7612182 |
Anti-IL-6 antibodies, compositions, methods and uses |
Nov. 3, 2009 |
| 7612181 |
Dual variable domain immunoglobulin and uses thereof |
Nov. 3, 2009 |
| 7611708 |
Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
Nov. 3, 2009 |
| 7611707 |
Glycoprotein VI antibodies and methods thereof |
Nov. 3, 2009 |
| 7611706 |
RG1 antibodies and uses thereof |
Nov. 3, 2009 |
| 7608696 |
IBC-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
Oct. 27, 2009 |
| 7608694 |
Antibody molecules having specificity for human IL-1.beta. |
Oct. 27, 2009 |
| 7608690 |
IL-B30 antibodies |
Oct. 27, 2009 |
| 7608264 |
Antibodies that bind to pleiotrophin growth factor receptor |
Oct. 27, 2009 |
| 7608263 |
RG1 antibodies and uses thereof |
Oct. 27, 2009 |
| 7605238 |
Human CTLA-4 antibodies and their uses |
Oct. 20, 2009 |
| 7605236 |
Antibodies that immunospecifically bind to B lymphocyte stimulator protein |
Oct. 20, 2009 |
| 7605234 |
Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof |
Oct. 20, 2009 |
| 7605233 |
Tumour necrosis factor binding ligands |
Oct. 20, 2009 |
| 7604800 |
Anti-PSGL-1 antibodies |
Oct. 20, 2009 |
| 7604799 |
EphA4 Antibodies |
Oct. 20, 2009 |
| 7601818 |
Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors |
Oct. 13, 2009 |
| 7601817 |
Antibody peg positional isomers, compositions comprising same, and use thereof |
Oct. 13, 2009 |
| 7601816 |
Antibodies to cyclooxygenase variants |
Oct. 13, 2009 |
| 7601814 |
Reducing the immunogenicity of fusion proteins |
Oct. 13, 2009 |
| 7601352 |
Monoclonal antibodies and antigen binding fragments thereof capable of binding TrkA and inhibiting the functional activation of TrkA |
Oct. 13, 2009 |
| 7601351 |
Antibodies against protective antigen |
Oct. 13, 2009 |
| 7598351 |
Antibody and use thereof |
Oct. 6, 2009 |
| 7597889 |
Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
Oct. 6, 2009 |
| 7597888 |
Glycoprotein VI and uses thereof |
Oct. 6, 2009 |
| 7597886 |
Tumor necrosis factor-gamma |
Oct. 6, 2009 |
| 7595380 |
Monoclonal antibodies and methods for their use in the detection of cervical disease |
Sep. 29, 2009 |
| 7595379 |
Antibodies and related molecules that bind to PSCA proteins |
Sep. 29, 2009 |
| 7595378 |
Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
Sep. 29, 2009 |
| 7595051 |
Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies |
Sep. 29, 2009 |
| 7595047 |
Compositions and methods for promoting or inhibiting angiogenesis |
Sep. 29, 2009 |
| 7592430 |
Antibodies to M-CSF |
Sep. 22, 2009 |
| 7592429 |
Sclerostin-binding antibody |
Sep. 22, 2009 |
| 7592427 |
Antibodies to IL-21 receptor |
Sep. 22, 2009 |
|
|
|
